![](/img/cover-not-exists.png)
LENALIDOMIDE AND RITUXIMAB (ReRi) AS FRONT LINE THERAPY OF ELDERLY FRAIL PATIENTS WITH DIFFUSE LARGE B-CELLS LYMPHOMA. FIRST PLANNED INTERIM ANALYSIS OF A PHASE II STUDY OF THE FONDAZIONE ITALIANA LINFOMI (FIL)
Gini, G., Tani, M., Bassan, R., Tucci, A., Ballerini, F., Sampaolo, M., Merli, F., Re, F., Annibali, O., Liberati, A., Visco, C., Arcari, A., Storti, S., Fabbri, A., Musuraca, G., Zilioli, V., Cox, M.Volume:
37
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.99_2631
Date:
June, 2019
File:
PDF, 215 KB
english, 2019